Innovations in immunohistochemistry for the haematopathologist

Annales de Pathologie

Volumn 27, Issue HS1, 2007, Pages 33-36

  Mason, D Y ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CD79A ANTIGEN; EPITOPE; MARKER; MONOCLONAL ANTIBODY; PARAFFIN; POLYCLONAL ANTIBODY; PROTEIN;

BIOCHEMISTRY; BLOOD DISEASE; CONFERENCE PAPER; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION PROFILING; GENETIC DISORDER; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; LYMPHOCYTE; LYMPHOID CELL; LYMPHOMA; MOLECULAR BIOLOGY; MOLECULE; PATHOLOGY; PROGNOSIS; TUMOR CELL;

EID: 37349035088     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0242-6498(07)92852-7     Document Type: Conference Paper

References (21)

1. Pozzobon M, Marafioti T, Hansmann ML, Natkunam Y, Mason DY. Intracellular signalling molecules as immunohistochemical markers of normal and neoplastic human leucocytes in routine biopsy samples. Br J Haematol 2004 ; 124 : 519-33.
2. Paterson JC, Tedoldi S, Craxton A, Jones M, Hansmann ML, Collins G et al. The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas. Haematologica 2006 ; 91 : 772-80.
3. Tedoldi S, Paterson JC, Hansmann ML, Natkunam Y, Rudiger T, Angelisova P et al. Transmembrane adaptor molecules: a new category of lymphoid-cell markers. Blood 2006 ; 107 : 213-21.
4. Pulford K, Banham AH, Lyne L, Jones M, Ippolito GC, Liu H et al. The BCL11AXL transcription factor: its distribution in normal and malignant tissues and use as a marker for plasmacytoid dendritic cells. Leukemia 2006 ; 20 : 1439-41.
5. Dorfman DM, Brown JA, Shahsafaei A, Freeman GJ. Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 2006 ; 30 : 802-10.
6. Dupuis J, Boye K, Martin N, Copie-Bergman C, Plonquet A, Fabiani B et al. Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells. Am J Surg Pathol 2006 ; 30 : 490-4.
7. Grogg KL, Attygalle AD, Macon WR, Remstein ED, Kurtin PJ, Dogan A. Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified. Mod Pathol 2006 ; 19 : 1101-7.
8. Roncador G, Verdes-Montenegro JFG, Tedoldi S, Paterson JC, Klapper W, Ballabio E et al. Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma. Haematologica 2007 (in press).
9. Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004 ; 103 : 275-82.
10. Marafioti T, Pozzobon M, Hansmann ML, Delsol G, Pileri SA, Mason DY. Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease. Blood 2004 ; 103 : 188-93.
11. Tedoldi S, Paterson JC, Cordell J, Tan SY, Jones M, Manek S et al. Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas. J Pathol 2006 ; 209 : 454-63.
12. Marafioti T, Jones M, Facchetti F, Diss TC, Du MQ, Isaacson PG et al. Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology. Blood 2003 ; 102 : 2868-76.
13. Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 2003 ; 198 : 851-62.
14. Savage KJ, Monti S, Kutok JL, Cattoretti G, Neuberg D, De Leval L et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 2003 ; 102 : 3871-9.
15. Natkunam Y, Mason DY. Prognostic immunohistologic markers in human tumors: why are so few used in clinical practice? Lab Invest 2006 ; 86 : 742-7.
16. Alvaro T, Lejeune M, Salvado MT, Bosch R, Garcia JF, Jaen J et al. Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res 2005 ; 11 : 1467-73.
17. Farinha P, Masoudi H, Skinnider BF, Shumansky K, Spinelli JJ, Gill K et al. Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood 2005 ; 106 : 2169-74.
18. Chang H, Stewart AK, Qi XY, Li ZH, Yi QL, Trudel S. Immunohistochemistry accurately predicts FGFR3 aberrant expression and t(4;14) in multiple myeloma. Blood 2005 ; 106 : 353-55.
19. Schraders M, de Jong D, Kluin P, Groenen P, van Krieken H. Lack of Bcl-2 expression in follicular lymphoma may be caused by mutations in the BCL2 gene or by absence of the t(14;18) translocation. J Pathol 2005 ; 205 : 329-35.
20. Ventura RA, Martin-Subero JI, Jones M, McParland J, Gesk S, Mason DY et al. FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. J Mol Diagn 2006 ; 8 : 141-51.
21. Mattsson G, Tan SY, Ferguson DJP, Erber W, Turner SH, Marafioti T et al. Detection of genetic alterations by ImmunoFISH analysis of whole cells extracted from routine biopsy material. J Mol Diag 2007 (in press).